Latest Breaking News On - John bisi - Page 1 : comparemela.com

Newly minted RTP cancer therapeutics developer Incyclix Bio has just received $30 million in Series B financing.

North carolinaUnited statesUniversity of north carolinaChapel hillResearch triangle parkJohn bisiLaura rowleyFred eshelmanPatrick robertsSid subramonyIncyclix bioJay strumLife science economic developmentUniversity of north carolina at chapel hillCarolina biotechnology centerArc therapeutics